Current Status of Neoadjuvant Endocrine Therapy in Early Stage Breast Cancer

被引：25

作者：

Reinert, Tomas ^{[1
,2
]}

Goncalves, Rodrigo ^{[3
]}

Ellis, Matthew J. ^{[4
]}

机构：

[1] Hosp Canc Mae Deus, Porto Alegre, RS, Brazil

[2] Fed Univ Rio Grande Sul UFRGS, Postgrad Dept Med Sci, Porto Alegre, RS, Brazil

[3] Univ Sao Paulo, Hosp Clin, Dept Obstet & Ginecol, Disciplina Ginecol,Fac Med,Setor Mastol, Sao Paulo, Brazil

[4] Baylor Coll Med, Lester & Sue Smith Breast Canc Ctr, Houston, TX 77030 USA

来源：

CURRENT TREATMENT OPTIONS IN ONCOLOGY | 2018年 / 19卷 / 05期

关键词：

Breast cancer; Endocrine therapy Neoadjuvant; Aromatase inhibitors; Breast-conserving surgery; PHASE-II TRIAL; RANDOMIZED-TRIAL; POSTMENOPAUSAL WOMEN; DOUBLE-BLIND; PREOPERATIVE TREATMENT; PROLIFERATION INDEX; OVARIAN SUPPRESSION; PROGNOSTIC VALUE; KI67; EXPRESSION; ELDERLY WOMEN;

D O I：

10.1007/s11864-018-0538-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Neoadjuvant endocrine therapy (NET) with Ki67-based response monitoring is a practical, cost-effective approach to the management of clinical stage II and III estrogen receptor-positive (ER+) breast cancer. In addition to marked improvements in rates of breast conservation, the identification of extreme responders on the basis of the preoperative endocrine prognostic index (PEPI) provides a rationale to avoid chemotherapy on the basis of highly favorable prognosis in some patients. Finally, samples accrued from patients treated with neoadjuvant therapy are providing valuable insights into the molecular basis for intrinsic resistance to endocrine therapy and promise a more rational basis and precise approach to the systemic treatment of ER+ breast cancer.

引用

页数：14

共 76 条

[21] Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study [J].

Eiermann, W ;

Paepke, S ;

Appfelstaedt, J ;

Llombart-Cussac, A ;

Eremin, J ;

Vinholes, J ;

Mauriac, L ;

Ellis, M ;

Lassus, M ;

Chaudri-Ross, HA ;

Dugan, M ;

Borgs, M ;

Semiglazov, V .

ANNALS OF ONCOLOGY, 2001, 12 (11) :1527-1532

[22] Phase III Study of Doxorubicin/Cyclophosphamide With Concomitant Versus Sequential Docetaxel As Adjuvant Treatment in Patients With Human Epidermal Growth Factor Receptor 2-Normal, Node-Positive Breast Cancer: BCIRG-005 Trial [J].

Eiermann, Wolfgang ;

Pienkowski, Tadeusz ;

Crown, John ;

Sadeghi, Saeed ;

Martin, Miguel ;

Chan, Arlene ;

Saleh, Mansoor ;

Sehdev, Sandeep ;

Provencher, Louise ;

Semiglazov, Vladimir ;

Press, Michael ;

Sauter, Guido ;

Lindsay, Mary-Ann ;

Riva, Alessandro ;

Buyse, Marc ;

Drevot, Philippe ;

Taupin, Henry ;

Mackey, John R. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (29) :3877-3884

[23] Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics [J].

Ellis, Matthew J. ;

Tao, Yu ;

Luo, Jingqin ;

A'Hern, Roger ;

Evans, Dean B. ;

Bhatnagar, Ajay S. ;

Ross, Hilary A. Chaudri ;

von Kameke, Alexander ;

Miller, William R. ;

Smith, Ian ;

Eiermann, Wolfgang ;

Dowsett, Mitch .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (19) :1380-1388

[24] Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance) [J].

Ellis, Matthew J. ;

Suman, Vera J. ;

Hoog, Jeremy ;

Goncalves, Rodrigo ;

Sanati, Souzan ;

Creighton, Chad J. ;

DeSchryver, Katherine ;

Crouch, Erika ;

Brink, Amy ;

Watson, Mark ;

Luo, Jingqin ;

Tao, Yu ;

Barnes, Michael ;

Dowsett, Mitchell ;

Budd, G. Thomas ;

Winer, Eric ;

Silverman, Paula ;

Esserman, Laura ;

Carey, Lisa ;

Ma, Cynthia X. ;

Unzeitig, Gary ;

Pluard, Timothy ;

Whitworth, Pat ;

Babiera, Gildy ;

Guenther, J. Michael ;

Dayao, Zoneddy ;

Ota, David ;

Leitch, Marilyn ;

Olson, John A., Jr. ;

Allred, D. Craig ;

Hunt, Kelly .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (10) :1061-+

[25] Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor-Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype-ACOSOG Z1031 [J].

Ellis, Matthew J. ;

Suman, Vera J. ;

Hoog, Jeremy ;

Lin, Li ;

Snider, Jacqueline ;

Prat, Aleix ;

Parker, Joel S. ;

Luo, Jingqin ;

DeSchryver, Katherine ;

Allred, D. Craig ;

Esserman, Laura J. ;

Unzeitig, Gary W. ;

Margenthaler, Julie ;

Babiera, Gildy V. ;

Marcom, P. Kelly ;

Guenther, Joseph M. ;

Watson, Mark A. ;

Leitch, Marilyn ;

Hunt, Kelly ;

Olson, John A. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (17) :2342-2349

[26] Late follow-up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer [J].

Fennessy, M ;

Bates, T ;

MacRae, K ;

Riley, D ;

Houghton, J ;

Baum, M .

BRITISH JOURNAL OF SURGERY, 2004, 91 (06) :699-704

[27] Effect of preoperative chemotherapy on the outcome of women with operable breast cancer [J].

Fisher, B ;

Bryant, J ;

Wolmark, N ;

Mamounas, E ;

Brown, A ;

Fisher, ER ;

Wickerham, DL ;

Begovic, M ;

DeCillis, A ;

Robidoux, A ;

Margolese, RG ;

Cruz, AB ;

Hoehn, JL ;

Lees, AW ;

Dimitrov, NV ;

Bear, HD .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2672-2685

[28] Intratumoral heterogeneity of Ki67 expression in early breast cancers exceeds variability between individual tumours [J].

Focke, Cornelia M. ;

Decker, Thomas ;

van Diest, Paul J. .

HISTOPATHOLOGY, 2016, 69 (05) :849-861

[29] Efficacy of six month neoadjuvant endocrine therapy in postmenopausal, hormone receptor-positive breast cancer patients - A phase II trial [J].

Fontein, Duveken B. Y. ;

Charehbili, Ayoub ;

Nortier, Johan W. R. ;

Kranenbarg, Elma Meershoek-Klein ;

Kroep, Judith R. ;

Putter, H. ;

van Riet, Yvonne ;

Nieuwenhuijzen, Grard A. P. ;

de Valk, Bart ;

Terwogt, Jetske M. Meerum ;

Algie, Gijs D. ;

Liefers, Gerrit-Jan ;

Linn, Sabine ;

van de Velde, Cornelis J. H. .

EUROPEAN JOURNAL OF CANCER, 2014, 50 (13) :2190-2200

[30] Adjuvant Ovarian Suppression in Premenopausal Breast Cancer [J].

Francis, Prudence A. ;

Regan, Meredith M. ;

Fleming, Gini F. ;

Lang, Istvan ;

Ciruelos, Eva ;

Bellet, Meritxell ;

Bonnefoi, Herve R. ;

Climent, Miguel A. ;

Da Prada, Gian Antonio ;

Burstein, Harold J. ;

Martino, Silvana ;

Davidson, Nancy E. ;

Geyer, Charles E., Jr. ;

Walley, Barbara A. ;

Coleman, Robert ;

Kerbrat, Pierre ;

Buchholz, Stefan ;

Ingle, James N. ;

Winer, Eric P. ;

Rabaglio-Poretti, Manuela ;

Maibach, Rudolf ;

Ruepp, Barbara ;

Giobbie-Hurder, Anita ;

Price, Karen N. ;

Colleoni, Marco ;

Viale, Giuseppe ;

Coates, Alan S. ;

Goldhirsch, Aron ;

Gelber, Richard D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (05) :436-446

← 1 2 3 4 5 6 7 8 →